Neural Epidermal Growth Factor-Like 1-Positive Membranous Nephropathy With Rheumatoid Arthritis

Kidney Int Rep. 2023 Jan 7;8(4):921-924. doi: 10.1016/j.ekir.2022.12.026. eCollection 2023 Apr.

Authors

Affiliations

¹ Division of Nephrology and Hypertension, The Jikei University School of Medicine, Tokyo, Japan.
² Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan.

No abstract available

Keywords: adalimumab; bucillamine; membranous nephropathy; nephrotic syndrome; neural epidermal growth factor-like 1; rheumatoid arthritis.